Simplify Asset Management »

Sarepta Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 193k 124.89
2024-06-30 $17M 105k 158.00
2024-03-31 $12M 91k 129.46
2023-12-31 $2.3M 24k 96.43

More positions owned by Simplify Asset Management

Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Simplify Exchange Traded Fun Natl Muni Bd Etf
Simplify Exchange Traded Fun Intmd Term Trsry (TYA)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Schwab Strategic Tr Us Tips Etf (SCHP)
Simplify Exchange Traded Fun High Yield Plus (CDX)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Sarepta Therapeutics (SRPT)
Applied Therapeutics (APLT)

View all positions for Simplify Asset Management

Top funds holding Sarepta Therapeutics

BlackRock
BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
State Street Corporation
Henderson Group
Morgan Stanley
Farallon Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
EcoR1 Capital
Citadel Advisors

View all funds holding Sarepta Therapeutics